• Slide3

Launch and Build

HiBEAM, a not-for-profit organization, was created to help launch and build high growth Hawaii technology, biotechnology and life sciences companies by providing expert professional advice and access to funding sources.

Taking Risks

HiBEAM will help develop in Hawaii an entrepreneurial culture that encourages risk-taking, enables local technology companies to compete successfully in global markets, attracts capital, strengthens and diversifies the economy, and creates well-paying jobs.


HiBEAM assembles teams of advisors for client companies. HiBEAM tailors the composition of each team to fit the specific needs and goals of the entrepreneur. Please visit our Programs page for more information.
Have great technology and want to grow? We can work with you. Please contact us.

Latest News

PRESS RELEASE: Avoid IP Piracy and Loss of Tech and Trade Secrets in China

FOR IMMEDIATE RELEASE Contact: Bee Leng Chua, HiBEAM, 808-722-6289 or bchua@hibeam.org Or Piia Aarma at Pineapple Tweed PR, 808-221-2102 or piia@pineappletweed.com AVOID IP PIRACY AND LOSS OF TECH AND TRADE SECRETS IN CHINA China Expert To Discuss IP And Tech Transfer Issues In China (HONOLULU, July 21, 2014) – Despite the appeal of the enormous China market, [...]

Hawaii-based TruTag Technologies wins another national award

Click Here for article.

Intellectual Property and Technology Transfer Issues in China

HiBEAM and the UH Cancer Center is organizing a talk by Mr. Loke-Khoon Tan, a Partner with Baker & McKenzie Hong Kong/China on the topic of: Intellectual Property and Technology Transfer Issues in China : Trends and Developments Friday, August 1, 3 pm to 5 pm Sullivan Conference Center, UH Cancer Center, 701 Ilalo Road, [...]

Hawaii Biotech receives an Anthrax grant award

Hawaii Biotech announced the award of a five year grant from the National Institute of Allergy and Infectious Diseases for the continued development of small molecule drugs to block the potentially lethal effects of Anthrax toxin. This award allows Hawaii Biotech to expand its product development efforts beyond vaccines to drug discovery and development. Hawaii [...]